tert-Butyl piperazine-1-carboxylate → HCID 22277394, compound
Reaction equation
[Si:1]([O:8][CH2:9][C:10]1[CH:11]=[C:12](Br)[C:13]2[O:17][CH:16]=[CH:15][C:14]=2[CH:18]=1)([C:4]([CH3:7])([CH3:6])[CH3:5])([CH3:3])[CH3:2].[C:20]([O:24][C:25]([N:27]1[CH2:32][CH2:31][NH:30][CH2:29][CH2:28]1)=[O:26])([CH3:23])([CH3:22])[CH3:21]>>[Si:1]([O:8][CH2:9][C:10]1[CH:11]=[C:12]([N:30]2[CH2:29][CH2:28][N:27]([C:25]([O:24][C:20]([CH3:23])([CH3:22])[CH3:21])=[O:26])[CH2:32][CH2:31]2)[C:13]2[O:17][CH:16]=[CH:15][C:14]=2[CH:18]=1)([C:4]([CH3:7])([CH3:6])[CH3:5])([CH3:3])[CH3:2]Participants
3
Procedure
Beginning with 0.51 gm (1.5 mMol) 5-(tert-butyldimethylsilyloxymethyl)-7-bromobenzofuran and 0.30 gm (1.6 mMol) 1-tert-butoxycarbonylpiperazine, 0.42 gm (63%) of the desired compound were prepared essentially as described in GENERAL PROCEDURE II.
Sources & evidence
- ORD record
- ord-e9ba55a7b28546ecb759b0f9f0c2e646
- Source dataset
- uspto-grants-2005_11
- Patent number
- US06967201B1
Reaction notes
Loading…